FDA Recall United States Terminated Historical recordClass II
Sam'S Club
- Product
- Member's Mark Hatch Chile Chicken Enchiladas, ready to cook,…
- Reason
- Presence of Listeria monocytogenes
- Published
- January 8, 2025
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.
37,060
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,786
Class I recallsReasonable probability of serious health consequences24,313
Class II recallsTemporary or medically reversible health consequences2,876
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,072 recalls
Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/freshpoint-issues-recall-due-improperly-declared-allergen-egg-chicken-salad-wedge-sandwichesPublished September 8, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,527 recalls have been announced year to date.
- Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
- The highest complete period was Jun 2026 (297).
- Sep 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,313 |
| Class I | 9,786 |
| Class III | 2,876 |
| Not Yet Classified | 2 |
| Class | Recalls |
|---|---|
| Class II | 24,313 |
| Class I | 9,786 |
| Class III | 2,876 |
| Not Yet Classified | 2 |
FDA Recall United States Terminated Historical recordClass I
Grimmway Enterprises, Inc. dba Grimmway Farms
- Product
- --- Organic Whole Carrots --- Organic Clip Carrots 50 Lbs C…
- Reason
- Potential contamination with E. coli O121:H19
- Published
- January 8, 2025
- Distribution
- Distribution Centers located in U.S. Sta…
FDA Recall United States Terminated Historical recordClass I
Grimmway Enterprises, Inc. dba Grimmway Farms
- Product
- --- Organic Whole Carrots --- Organic Carrot 125/6 Cal-Orga…
- Reason
- Potential contamination with E. coli O121:H19
- Published
- January 8, 2025
- Distribution
- Distribution Centers located in U.S. Sta…
FDA Recall United States Terminated Historical recordClass I
Grimmway Enterprises, Inc. dba Grimmway Farms
- Product
- --- Organic Baby Carrots --- Organic Baby Carrots 25 Grimmwa…
- Reason
- Potential contamination with E. coli O121:H19
- Published
- January 8, 2025
- Distribution
- Distribution Centers located in U.S. Sta…
FDA Recall United States Terminated Historical recordClass I
Grimmway Enterprises, Inc. dba Grimmway Farms
- Product
- --- Organic Baby Carrots --- Orangic Baby Peeled Carrots 13/…
- Reason
- Potential contamination with E. coli O121:H19
- Published
- January 8, 2025
- Distribution
- Distribution Centers located in U.S. Sta…
FDA Recall United States Terminated Historical recordClass I
Grimmway Enterprises, Inc. dba Grimmway Farms
- Product
- --- Organic Baby Carrots --- Organic Baby Peeled Carrots 12/…
- Reason
- Potential contamination with E. coli O121:H19
- Published
- January 8, 2025
- Distribution
- Distribution Centers located in U.S. Sta…
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Rising Pharma, Inc., Allendale, NJ, Repackaged by: RemedyRepack Inc., Indiana, PA
- Reason
- CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
Kit for the Preparation of Technetium Tc 99m Sestamibi Injection, Each Kit contains: 30 sterile and non-pyrogenic reaction vials each containing Tetrakis (2-methoxy isobutyl isonitrile) Copper (I) tetratluoroborate - 1 mg; Stannous Chloride Dihydrate - 0.D75 mg; L-Cysteine Hydrochloride Monohydrate - 1 mg; Sodium Citrate Dihydrate - 2.6 mg; Mannitol - 20 mg. The pH is adjusted to 5.6 to 5.7 with HCI or NaOH prior to lyophilization. Sealed under nitrogen. 30 Radioassay Information Labels with radiation warning symbol. 1 package insert, Rx only, Manufacture by: Curium US LLC, Maryland Heights, MO 63043, 69945-092-40
- Reason
- Lack of Assurance of Sterility; Improper crimps on vials impacting the integrity of the product
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (NDC 51991-748-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
- Reason
- CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (NDC 51991-747-90) Mfr. by: Towa Pharmaceutical Europe, S.L. Martorelles, (Barcelona), Spain, Dist. by: Breckenridge Pharmaceuticals, Inc., Berkeley Heights, NJ 07922.
- Reason
- CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01
- Reason
- CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-861-01
- Reason
- CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-08
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-415-04
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-05
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall Ongoing Historical recordClass II
Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04
- Reason
- CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.
- Published
- January 1, 2025
- Distribution
- Nationwide
FDA Recall United States Terminated Historical recordClass II
Borsari Food Company Inc
- Product
- BORSARI Food Company Incorporated; BLOODY MARY MIX ; 32 FL.…
- Reason
- Product contains undeclared fish (anchovy) and soy.
- Published
- January 1, 2025
- Distribution
- Multiple states
FDA Recall Ongoing Historical recordClass II
Olanzapine Tablets, USP 2.5 mg, 30-count bottle, Rx Only, Manufactured for: Macleods Pharma USA, Inc. Princeton, NJ 08540, Manufactured for: Macleods Pharma USA Inc. Princeton, NJ,08540: Manufactured by: Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA, NDC 33342-067-07.
- Reason
- Failed Impurities/Degradation Specifications
- Published
- December 25, 2024
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
PROFESSIONAL Regener-Eyes, Ophthalmic Solution (glycerin 0.5%) , 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-003-01
- Reason
- Lack of Sterility Assurance
- Published
- December 25, 2024
- Distribution
- Nationwide
FDA Recall Terminated Historical recordClass II
LITE Regener-Eyes, Ophthalmic Solution (glycerin 0.4%), 3mL bottles, Distributed by: Regener-Eyes, Tampa, FL; Manufactured by: Regenerative Processing Plant, LLC, 34176 US HWY 19N, FL, NDC 82305-006-01
- Reason
- Lack of Sterility Assurance
- Published
- December 25, 2024
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.
